$400 savings end in:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
2026 Agenda: Day 3 - Wednesday 14 January - PT (Pacific Time, GMT-08:00)
After a challenging few years, the biotech sector may be entering a period of renewed opportunity. This session will explore emerging investment trends, acquisitions, and the factors driving optimism for the next wave of biotech innovation.
AI and quantum computing are reshaping the pharmaceutical industry by optimizing every stage of the drug development lifecycle. Hear from our panel of experts how these technologies allow researchers to uncover insights from large datasets and identify complex patterns. Beyond drug discovery, AI is poised to transform therapeutic development across research, clinical trials, regulatory submissions, and manufacturing processes.
Women’s health goes far beyond maternal and reproductive care, representing a substantial opportunity for value creation and societal impact. The Gates Foundation said it would commit $2.5 billion through 2030 to support dozens of different approaches for improving women’s health, from new medicines to prevent maternal mortality to vaccines to curb infections that disproportionately affect women. Is women’s health finally getting the attention it deserves? This session will explore emerging innovations and investment opportunities driving the next wave of transformation in women’s healthcare.
The traditional closing discussion at Biotech Showcase where journalists are invited to discuss what was “heard around the square” and Biotech Showcase during the most important week in the biotech calendar.
Explore the latest breakthroughs in neuroscience, from novel therapeutic approaches to cutting-edge diagnostics. Join this panel to learn about their strategies, technologies, and collaborations, shaping the next generation of brain health solutions.
Hear from this panel how cutting-edge approaches are reshaping treatment paradigms and unlocking new opportunities in immune-based therapeutics.
In 2026, can early-stage biotech companies expect a rise in venture capital activity? Leading investors will explore strategies to leverage increased investment, secondary markets and IPO opportunities, strategic partnerships, and investment trends shaping biotech ventures.